Laurice Yang, MD
Clinical Neurophysiology · Stanford, CANPI 1053545822
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $624 of the $924 with a category attached, or 67.5%. Medtronic accounts for 67.5% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for clinical neurophysiology clinicians in CA, where the typical reported total is $1,149.
Across 6 payments — averaging $154.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$624
- Boston Scientific$223
- AbbVie$77
Across 12 payments — averaging $39,777 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$422K
- Eli Lilly$55K
What the payments were for
- Travel & lodging$62468%
- Food & beverage$30032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 2 | $624 |
| Boston Scientific | 1 | $223 |
| AbbVie | 3 | $77 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$924 in reported general payments places this provider in the 40th percentile of 49 clinical neurophysiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RytaryCarbidopa/Levodopa | 34 | $66,097 |
| Rasagiline Mesylate | 38 | $13,708 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 172 | $9,888 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 102 | $4,766 |
| AmantadineAmantadine Hcl | 55 | $2,546 |
| Ropinirole ErRopinirole Hcl | 14 | $2,345 |
| Gabapentin | 55 | $1,351 |
| RivastigmineRivastigmine Tartrate | 20 | $969 |
| Clonazepam | 60 | $541 |
| Pregabalin | 22 | $414 |
| Baclofen | 22 | $399 |
| Propranolol Hcl | 14 | $390 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 11 | $339 |
Paid to pharmacies, not to this prescriber.
Other clinical neurophysiology in Stanford
- Christopher LockStanford$159K
- Srikanth MuppidiStanford$150K
- Mitchell MiglisStanford$51K
- Safwan JaradehStanford$34K
- Margaret FerrisStanford$18K
- Kathleen PostonStanford$18K
- Helen Bronte-StewartStanford$7K
- Jaime LopezStanford$1K
- Sungho ChoStanford$1K
- Felix ChangStanford$974
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.